Menu
Warning! You won't be able to use the quotation basket until you enable cookies in your Web browser.
Warning! Your Web browser is no longer supported. Please upgrade to a modern browser.

Aperio Digital Pathology Reinforces its Commitment to AACR

Published: 

VISTA, CA – April 18, 2016 – Leica Biosystems announced today that, as part of its continued commitment to cancer research, it will exhibit its leading edge Aperio LV1* and Aperio VERSA* digital pathology systems, and demonstrate its new, Aperio Image Analysis Algorithms* at the ACCR meeting in New Orleans, April 16 – 20. Leica Biosystems mission to advance cancer diagnostics, improving patient’s lives, is directly aligned with ACCR’s 2016 focus: Delivering Cures through Cancer Science, reinforcing the inextricable link between research and advances in patient care.

“We know, first hand, how important cancer research is to advancing patient care,” said Anne Brumme, vice president, image capture for Leica Biosystems Pathology Imaging Business. “We had an employee who was diagnosed with stage four cancer and given three months to live. By digitizing her glass slides and sending them to the right subspecialist, she found out that she qualified for a clinical trial that has now helped to extend her life by over three years and still counting. This is just one of many success stories that highlight the incredible work done by the life sciences community.”

“At the core of everything we do, Leica Biosystems realizes that, behind every glass slide, there are patients and families. That’s what brings us together,” stated Puneet Sarin, vice president and general manager of Leica Biosystems Pathology Imaging Business. ”Improving people’s lives is our ultimate, overarching purpose and we know that this is our customer’s mission, too. We want to be an integral part of cancer research; it’s our commitment.”

The Aperio VERSA, Aperio LV1, and Aperio Image Analysis Algorithms are valuable tools for researchers. Visit booth #640 for a live, educational, and hands-on experience. View the videos below for a preview of these latest innovations for cancer research.

Aperio VERSA*

The Aperio VERSA is a robust, versatile, digital pathology scanner with superior image quality and single click operation. It also provides optimal resolution for investigation of every slide in your facility. View the Aperio VERSA video to learn about the fast, flexible and easy-to-use system.

Aperio LV1*, a real time, live view digital pathology system, is a compact, economic solution for researchers looking to adopt Digital Pathology. View the Aperio LV1 video to see how you can access live slides in 15 seconds.

 

*About Aperio Digital Pathology Solutions
Aperio LV1, Aperio VERSA and Aperio Image Analysis Algorithms: *For Research Use Only. Not for use in diagnostic procedures.

About Leica Biosystems
Leica Biosystems (LeicaBiosystems.com) is a global leader in workflow solutions and automation, integrating each step in the workflow. As the only company to own the workflow from biopsy to diagnosis, we are uniquely positioned to break down the barriers between each of these steps. Our mission of “Advancing Cancer Diagnostics, Improving Lives” is at the heart of our corporate culture. Our easy-to-use and consistently reliable offerings help improve workflow efficiency and diagnostic confidence. The company is represented in over 100 countries and is headquartered in Nussloch, Germany.